These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 8959146)

  • 1. Relapse after short-course chemotherapy of patients with sputum smear-positive pulmonary tuberculosis under routine conditions with additional information on side effects and contact tracing.
    Martinez FD; Hernandez HM
    Tuber Lung Dis; 1996 Oct; 77(5):425-8. PubMed ID: 8959146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Viable Mycobacterium tuberculosis in sputum after pulmonary tuberculosis cure.
    Ambreen A; Jamil M; Rahman MAU; Mustafa T
    BMC Infect Dis; 2019 Oct; 19(1):923. PubMed ID: 31666021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between sputum smear grading and smear conversion rate and treatment outcome in the patients of pulmonary tuberculosis undergoing dots--a prospective cohort study.
    Tiwari S; Kumar A; Kapoor SK
    Indian J Tuberc; 2012 Jul; 59(3):135-40. PubMed ID: 23362709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Follow-up observation on relapse of smear negative pulmonary tuberculosis after short-course chemotherapy].
    Xu WG; Gao Z; Fan BD
    Zhonghua Jie He He Hu Xi Za Zhi; 2003 Feb; 26(2):74-6. PubMed ID: 12783655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Logistic analysis on risk factors related to smear positive pulmonary tuberculosis].
    Li XT; Ye LX; Shi LY; Xiao AQ; Hou SY; Wang W; Ye JJ; Tang SW; Zhao HH; Xu HT
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Aug; 25(8):658-60. PubMed ID: 15555385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
    API Consensus Expert Committee
    J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non conversion of sputum smears in new smear positive pulmonary tuberculosis patients in Yaoundé, Cameroon.
    Kuaban C; Bame R; Mouangue L; Djella S; Yomgni C
    East Afr Med J; 2009 May; 86(5):219-25. PubMed ID: 20084990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The results of retreatment of pulmonary tuberculosis using a short 6-month protocol 1985-1991 in the pneumo-phthisiology department of the Point G hospital in Bamako].
    Kayantao D; Keïta B; Sangaré S
    Bull Soc Pathol Exot; 1997; 90(2):124-7. PubMed ID: 9289251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sputum-smear-negative pulmonary tuberculosis: controlled trial of 3-month and 2-month regimens of chemotherapy.
    Lancet; 1979 Jun; 1(8131):1361-3. PubMed ID: 87829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Fully supervised ambulatory short-course chemotherapy with an intermittent regimen for newly diagnosed smear-positive pulmonary tuberculosis].
    Xu RX
    Zhonghua Jie He He Hu Xi Za Zhi; 1987 Oct; 10(5):261-3, 307. PubMed ID: 3131029
    [No Abstract]   [Full Text] [Related]  

  • 11. Extension of the intensive phase reduces unfavourable outcomes with the 8-month thioacetazone regimen.
    Van Deun A; Aung KJ; Hamid Salim MA; Ali MA; Naha MS; Das PK; Hossain MA; Declercq E
    Int J Tuberc Lung Dis; 2006 Nov; 10(11):1255-61. PubMed ID: 17131785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Control of tuberculosis by community health workers in Bangladesh.
    Chowdhury AM; Chowdhury S; Islam MN; Islam A; Vaughan JP
    Lancet; 1997 Jul; 350(9072):169-72. PubMed ID: 9250184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A controlled trial of a 2-month, 3-month, and 12-month regimens of chemotherapy for sputum smear-negative pulmonary tuberculosis: the results at 30 months. Hong Kong Chest Service/Tuberculosis Research Centre, Madras/British Medical Research Council.
    Am Rev Respir Dis; 1981 Aug; 124(2):138-42. PubMed ID: 6789733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Should we take a history of prior treatment, and check sputum status at 2-3 months when treating patients for tuberculosis?
    Wilkinson D; Bechan S; Connolly C; Standing E; Short GM
    Int J Tuberc Lung Dis; 1998 Jan; 2(1):52-5. PubMed ID: 9562111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Should chemotherapy for pulmonary tuberculosis be started after the completion of pretreatment sputum examination?].
    Ito K; Aono A; Yoshiyama T; Wada M; Ogata H
    Kekkaku; 2005 Dec; 80(12):735-41. PubMed ID: 16447786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of a combined preparation of isoniazid, rifampicin and pyrazinamide (Rifater) in the initial phase of chemotherapy in three 6-month regimens for smear-positive pulmonary tuberculosis: a five-year follow-up report.
    Teo SK
    Int J Tuberc Lung Dis; 1999 Feb; 3(2):126-32. PubMed ID: 10091877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Efficacy of unfixed continuation phase short-course chemotherapy].
    Xiao C; Fu Y; Li Z
    Zhonghua Jie He He Hu Xi Za Zhi; 1997 Dec; 20(6):358-60. PubMed ID: 10374447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short-course chemotherapy in pulmonary tuberculosis. A controlled trial by the British Thoracic and Tuberculosis Association.
    Lancet; 1975 Jan; 1(7899):119-24. PubMed ID: 46047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-course chemotherapy for tuberculosis with mainly twice-weekly isoniazid and rifampin. Community physicians' seven-year experience with mainly outpatients.
    Dutt AK; Moers D; Stead WW
    Am J Med; 1984 Aug; 77(2):233-42. PubMed ID: 6431810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modified short-course chemotherapy of pulmonary tuberculosis in Ibadan, Nigeria--a preliminary report.
    Ige OM; Bakare NA; Onadeko BO
    Afr J Med Med Sci; 2000 Mar; 29(1):51-3. PubMed ID: 11379469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.